Overall Score

Growth

Revenue base remains modest, with revenue per share at 3.17 and asset turnover at 0.10, limiting organic growth visibility.

High gross margin of 80.5% and EBITDA margin of 70.0% support earnings expansion if portfolio income scales.

Profitability

Return on equity is 3.0% and return on invested capital is 4.1%, indicating only modest capital efficiency.

Operating margin is strong at 44.1% and net margin is 15.1%, but pretax margin is constrained by interest burden and leverage.

Financial Health

Liquidity is solid with a current ratio of 3.92 and cash ratio of 1.45.

Leverage remains elevated with debt-to-equity at 1.04 and net debt to EBITDA at 7.16, while interest coverage is only 1.20x.

Valuation

Valuation looks reasonable on cash flow, with price to free cash flow at 7.48 and free cash flow yield at 13.4%.

Price to book is 0.83 and price to sales is 4.09, suggesting the market is not pricing in aggressive growth.